ModelEdge

Jazz Pharmaceuticals
JAZZ
Filing Type10-Q
Filing Date5/1/2024
Updated5/2/24, 5:38 AM

Filing

10-Q
Earnings Release

Exhibits

10-QQ1
EX-10.1OFFER LETTER
EX-10.2AMENDED AND RESTATED NON-EMPLOYEE DIRECTOR COMPENSATION POLICY
EX-31.1CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A)
EX-31.2CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A)
EX-32.1CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350